9069 Results

Journal Article

Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension

Authors: Ling-Long Tang, Lei Chen, Yan-Ping Mao, Wen-Fei Li, Ying Sun, Li-Zhi Liu, Ai-Hua Lin, Hai-Qiang Mai, Jian-Yong Shao, Li Li, Jun Ma

Congress Abstract

Fractionation and early mortality in palliative radiotherapy across the English NHS

Authors: Spencer|, Katie(1)*[katie.spencer1@nhs.net];Hall|, Peter(2);Henry|, Ann(3);Velikova|, Galina(3);Whalley|, Simon(4);Birch|, Rebecca(4);Le Calvez|, Kerlann(5);Williams|, Matt(6);Morris|, Eva(4);
(1)University of Leeds, Leeds Institute of Health Sciences, Leeds, United Kingdom;(2)Edinburgh University, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom;(3)University of Leeds, Leeds Institute of Medical Research, Leeds, United Kingdom;(4)University of Leeds, Leeds Institute of Data Analytics, Leeds, United Kingdom;(5)Imperial College Healthcare NHS Trust, Radiotherapy department, Leeds, United Kingdom;(6)Imperial College, Department of Surgery and Cancer, London, United Kingdom;
Show Affiliations

Journal Article

Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial

Authors: Alfonso Gomez-Iturriaga, David Buchser, Esther Mayrata, Iñigo San Miguel, Alba Gonzalez, Fernan Suarez, Lorea Martinez-Indart, Pablo Minguez, Jose Espinosa, Fernando Perez, Jon Cacicedo, Francisco Casquero

Congress Abstract

Low-dose radiotherapy as a chemosensitizer of neoadjuvant chemotherapy for LA-NPC: a phase II trial

Authors:

Mei Feng1,2, Qingping Yin3, Yunxiang Qi3, Lu Li1, Mei Lan1, Xin Lai1, Ming Fan1, Jun Zhang1, Fang Li4, Weidong Wang4, Jinyi Lang1

1Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Department of Radiation Oncology, Chengdu, China; 2The Third People's Hospital of Sichuan Province, Department of Oncology, Chengdu, China; 3 Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Department of Radiation Oncology, Chengdu, China; 4Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Department of Radiation Oncolog, Chengdu, China

Show Affiliations

Journal Article

Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion

Authors: Tony Hsiang-Kuang Liang, Sung-Hsin Kuo, Chun-Wei Wang, Wan-Yu Chen, Che-Yu Hsu, Shih-Fan Lai, Ham-Min Tseng, San-Lin You, Chung-Ming Chen, Wen-Yih Isaac Tseng

Journal Article

Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness

Authors: Apostolos Menegakis, Chiara De Colle, Ala Yaromina, Joerg Hennenlotter, Arnulf Stenzl, Marcus Scharpf, Falko Fend, Susan Noell, Marcos Tatagiba, Sara Brucker, Diethelm Wallwiener, Simon Boeke, Umberto Ricardi, Michael Baumann, Daniel Zips

Journal Article

A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy

Authors: Zhou Huang, Mei Shi, Wei-Hu Wang, Liang-Fang Shen, Yu Tang, Qing-Lin Rong, Li Zhu, Xiao-Bo Huang, Jian Tie, Jia-Yi Chen, Jun Zhang, Hong-Fen Wu, Jing Cheng, Min Liu, Chang-Ying Ma, Shu-Lian Wang, Ye-Xiong Li

Congress Abstract

Validation of a companion diagnostic biomarker for prospective use in prostate radiotherapy trials

Authors: Thiruthaneeswaran|, Niluja(1,2)*[nilujat@ausdoctors.net];Bibby|, Becky A S(1);Pereira|, Ronnie(3);More|, Elisabet(1);Bristow|, Robert G(3,4);Choudhury|, Ananya(1);West|, Catharine (1);
(1)University of Manchester, Translational Radiobiology, Manchester, United Kingdom;(2)University of Sydney, Sydney Medical School, Sydney, Australia;(3)University of Manchester, Translational Oncogenomics, Manchester, United Kingdom;(4)Manchester Cancer Research Centre, The Oglesby Cancer Research Building, Manchester, United Kingdom;
Show Affiliations

Journal Article

Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: Comparison with sequential boost in a randomized trial

Authors: Hans Van Hulle, Eline Desaunois, Vincent Vakaet, Leen Paelinck, Max Schoepen, Giselle Post, Annick Van Greveling, Bruno Speleers, Marc Mareel, Wilfried De Neve, Chris Monten, Pieter Deseyne, Liv Veldeman
*:*